Eastern Bank
MDGL icon

Eastern Bank’s Madrigal Pharmaceuticals MDGL Stock Holding History

Eastern Bank’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$32.8K Hold
65
– – ﹤0.01% 701
2026
Q2 		$34.9K Sell
65
-21
-24% -$10.8K ﹤0.01% 672
2026
Q1 		$45K Hold
86
– – ﹤0.01% 586
2025
Q4 		$50.1K Buy
86
+21
+32% +$10.7K ﹤0.01% 571
2025
Q3 		$29.8K Hold
65
– – ﹤0.01% 657
2025
Q2 		$19.7K Hold
65
– – ﹤0.01% 680
2025
Q1 		$21.5K Hold
65
– – ﹤0.01% 679
2024
Q4 		$20.1K Hold
65
– – ﹤0.01% 694
2024
Q3 		$13.8K Buy
+65
New +$16.6K ﹤0.01% 729

Other funds holding MDGL

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Bourgeon Capital Management
Bourgeon Capital Management Darien, Connecticut $696M AUM 39.92% 1-Year Est. Return
Shikiar Asset Management
Shikiar Asset Management New York $398M AUM 33.64% 1-Year Est. Return
Stanley-Laman Group
Stanley-Laman Group Berwyn, Pennsylvania $915M AUM 50.26% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Newbridge Financial Services Group
Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return
SGH
Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return
Quadrant Capital Group
Quadrant Capital Group Cincinnati, Ohio $3.7B AUM 33.76% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Eastern Bank's MDGL Position: Q3 2026 in Review

Eastern Bank held its Madrigal Pharmaceuticals (MDGL) position steady in Q3 2026 at 65 shares worth $32.8K. The position accounts for ﹤0.01% of the portfolio, ranked #701.

Eastern Bank first reported a position in MDGL in Q3 2024 and has held it in 9 quarters since. The position peaked at $50.1K in Q4 2025. 46 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • Eastern Bank held 65 shares of Madrigal Pharmaceuticals worth $32.8K as of Q3 2026.
  • Eastern Bank left its Madrigal Pharmaceuticals share count unchanged in Q3 2026.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #701 holding.
  • Eastern Bank first reported a position in Madrigal Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
  • Eastern Bank's Madrigal Pharmaceuticals position peaked at $50.1K in Q4 2025.
  • 46 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.